» Articles » PMID: 37237494

The Post-Antibiotic Era: A New Dawn for Bacteriophages

Overview
Journal Biology (Basel)
Publisher MDPI
Specialty Biology
Date 2023 May 27
PMID 37237494
Authors
Affiliations
Soon will be listed here.
Abstract

Phages are the most biologically diverse entities in the biosphere, infecting specific bacteria. Lytic phages quickly kill bacteria, while lysogenic phages integrate their genomes into bacteria and reproduce within the bacteria, participating in the evolution of natural populations. Thus, lytic phages are used to treat bacterial infections. However, due to the huge virus invasion, bacteria have also evolved a special immune mechanism (CRISPR-Cas systems, discovered in 1987). Therefore, it is necessary to develop phage cocktails and synthetic biology methods to infect bacteria, especially against multidrug-resistant bacteria infections, which are a major global threat. This review outlines the discovery and classification of phages and the associated achievements in the past century. The main applications of phages, including synthetic biology and PT, are also discussed, in addition to the effects of PT on immunity, intestinal microbes, and potential safety concerns. In the future, combining bioinformatics, synthetic biology, and classic phage research will be the way to deepen our understanding of phages. Overall, whether phages are an important element of the ecosystem or a carrier that mediates synthetic biology, they will greatly promote the progress of human society.

Citing Articles

Beyond Antibiotics: Exploring the Potential of Bacteriophages and Phage Therapy.

Biswas S, Sumon M, Ahmed S, Ruma R, Parvin A, Paul D Phage (New Rochelle). 2025; 5(4):186-202.

PMID: 40045940 PMC: 11876823. DOI: 10.1089/phage.2024.0005.


The Biological Characteristics of Phage Henu3 and the Fitness Cost Associated with Its Resistant Strains.

Li X, Xu J, Wang Y, Gomaa S, Zhao H, Teng T Int J Mol Sci. 2024; 25(17).

PMID: 39273250 PMC: 11394830. DOI: 10.3390/ijms25179301.


Antimicrobial resistance profiles of isolated from clinical and environmental samples: findings and implications.

Kasanga M, Shempela D, Daka V, Mwikisa M, Sikalima J, Chanda D JAC Antimicrob Resist. 2024; 6(2):dlae061.

PMID: 38680604 PMC: 11055401. DOI: 10.1093/jacamr/dlae061.

References
1.
Tan X, Chen H, Zhang M, Zhao Y, Jiang Y, Liu X . Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease. Front Cell Infect Microbiol. 2021; 11:631585. PMC: 7952606. DOI: 10.3389/fcimb.2021.631585. View

2.
Hatoum-Aslan A . Phage Genetic Engineering Using CRISPR⁻Cas Systems. Viruses. 2018; 10(6). PMC: 6024849. DOI: 10.3390/v10060335. View

3.
Box A, McGuffie M, OHara B, Seed K . Functional Analysis of Bacteriophage Immunity through a Type I-E CRISPR-Cas System in Vibrio cholerae and Its Application in Bacteriophage Genome Engineering. J Bacteriol. 2015; 198(3):578-90. PMC: 4719448. DOI: 10.1128/JB.00747-15. View

4.
Berdy J . Thoughts and facts about antibiotics: where we are now and where we are heading. J Antibiot (Tokyo). 2012; 65(8):385-95. DOI: 10.1038/ja.2012.27. View

5.
Martinez J, Coque T, Baquero F . What is a resistance gene? Ranking risk in resistomes. Nat Rev Microbiol. 2014; 13(2):116-23. DOI: 10.1038/nrmicro3399. View